GLYCOMIMETICS INC (GLYC) Net Income (Loss) Attributable to Parent USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Glycomimetics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2024.
  • Glycomimetics Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$10.7 M, a 3.64% decline year-over-year.
  • Glycomimetics Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$37.3 M, a 12.1% increase year-over-year.
  • Glycomimetics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$36.9 M, a 21% increase from 2022.
  • Glycomimetics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$46.7 M, a 26.4% increase from 2021.
  • Glycomimetics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$63.4 M, a 24.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$37.3 M -$10.7 M -$377 K -3.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$36.9 M -$9.08 M +$1.17 M +11.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$38.1 M -$9.2 M -$679 K -7.96% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$37.4 M -$8.26 M +$5.01 M +37.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-03
Q1 2023 -$42.4 M -$10.4 M +$4.29 M +29.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$46.7 M -$10.2 M +$7.18 M +41.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$53.9 M -$8.52 M +$8.81 M +50.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$62.7 M -$13.3 M +$1.13 M +7.86% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$63.8 M -$14.7 M -$379 K -2.66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$63.4 M -$17.4 M -$1.86 M -11.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 -$61.6 M -$17.3 M -$3.61 M -26.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$58 M -$14.4 M -$320 K -2.28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$57.6 M -$14.3 M -$6.61 M -86.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$51 M -$15.6 M -$836 K -5.68% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 -$50.2 M -$13.7 M -$471 K -3.55% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$49.7 M -$14.1 M +$1.75 M +11.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$51.5 M -$7.66 M +$6.42 M +45.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$57.9 M -$14.7 M -$819 K -5.89% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 -$57.1 M -$13.3 M -$1.68 M -14.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$55.4 M -$15.8 M -$4.55 M -40.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$50.8 M -$14.1 M -$2.57 M -22.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$48.3 M -$13.9 M -$4.65 M -50.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$43.6 M -$11.6 M -$3.63 M -45.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$40 M -$11.3 M -$3.14 M -38.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$36.9 M -$11.5 M -$3.58 M -45.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$33.3 M -$9.26 M -$929 K -11.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$32.4 M -$7.95 M -$95.4 K -1.22% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$32.3 M -$8.14 M -$70.2 K -0.87% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$32.2 M -$7.93 M -$376 K -4.98% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$31.8 M -$8.33 M +$553 K +6.23% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$32.4 M -$7.85 M -$687 K -9.58% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$31.7 M -$8.07 M -$18.5 M -178% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$13.2 M -$7.55 M -$446 K -6.27% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$12.8 M -$8.88 M -$1.49 M -20.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$11.3 M -$7.17 M -$550 K -8.32% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$10.7 M $10.4 M +$2.4 M +30% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$13.1 M -$7.11 M -$2.01 M -39.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$11.1 M -$7.39 M -$3.53 M -91.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$7.6 M -$6.62 M -$2.92 M -78.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$4.68 M $7.99 M +$11.5 M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$16.2 M -$5.1 M -$5.56 M -1210% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$10.6 M -$3.87 M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$3.7 M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$3.5 M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 $460 K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.